Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin-Reference-Cited by-同舟云学术

Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin

Published:2016-02 Issue:3 Volume:155 Page:431-440
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Campbell Marcia R.,Zhang Hui,Ziaee Shabnam,Ruiz-Saenz Ana,Gulizia Nathaniel,Oeffinger Julie,Amin Dhara N.,Ahuja Deepika,Moasser Mark M.,Park Catherine C.

Funder

American Association for Cancer Research

Susan G. Komen for the Cure

National Cancer Institute

California Breast Cancer Research Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3698-y.pdf

Reference40 articles.

1. Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19(56):6550–6565

2. Wieduwilt MJ, Moasser MM (2008) The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 65(10):1566–1584. doi: 10.1007/s00018-008-7440-8

3. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10(1):9–22. doi: 10.1038/nrc2748

4. Rathinam R, Alahari SK (2010) Important role of integrins in the cancer biology. Cancer metastasis reviews 29(1):223–237. doi: 10.1007/s10555-010-9211-x

5. Cox D, Brennan M, Moran N (2010) Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov 9(10):804–820. doi: 10.1038/nrd3266

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance;Seminars in Cancer Biology;2022-11

2. An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family;PLOS ONE;2022-09-15

3. The HER family as therapeutic targets in colorectal cancer;Critical Reviews in Oncology/Hematology;2022-06

4. Fabrication and investigation potential effect of lentinan and docetaxel nanofibers for synergistic treatment of breast cancer in vitro;Polymers for Advanced Technologies;2022-01-31

5. The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers;Scientific Reports;2021-04-27